140 related articles for article (PubMed ID: 22551422)
1. IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial.
Jensen AD; Nikoghosyan AV; Lossner K; Herfarth KK; Debus J; Münter MW
BMC Cancer; 2012 May; 12():163. PubMed ID: 22551422
[TBL] [Abstract][Full Text] [Related]
2. Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response.
Jensen AD; Nikoghosyan AV; Ecker S; Ellerbrock M; Debus J; Herfarth KK; Münter MW
Radiat Oncol; 2011 Nov; 6():149. PubMed ID: 22046954
[TBL] [Abstract][Full Text] [Related]
3. COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.
Jensen AD; Nikoghosyan AV; Lossner K; Haberer T; Jäkel O; Münter MW; Debus J
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):37-46. PubMed ID: 26279022
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC.
Jensen AD; Nikoghosyan A; Windemuth-Kieselbach C; Debus J; Münter MW
BMC Cancer; 2010 Oct; 10():546. PubMed ID: 20937120
[TBL] [Abstract][Full Text] [Related]
5. Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?
Jensen AD; Poulakis M; Vanoni V; Uhl M; Chaudhri N; Federspil PA; Freier K; Krauss J; Debus J
Radiat Oncol; 2016 Jul; 11(1):90. PubMed ID: 27386864
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of iodine-125 permanent brachytherapy versus intensity-modulated radiation for inoperable salivary gland malignancies: study protocol of a randomised controlled trial.
Liu SM; Wang HB; Sun Y; Shi Y; Zhang J; Huang MW; Zheng L; Lv XM; Zheng BM; Reilly KH; Yan XY; Ji P; Wu YF; Zhang JG
BMC Cancer; 2016 Mar; 16():193. PubMed ID: 26951097
[TBL] [Abstract][Full Text] [Related]
7. Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.
Jensen AD; Nikoghosyan AV; Poulakis M; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
Cancer; 2015 Sep; 121(17):3001-9. PubMed ID: 26043145
[TBL] [Abstract][Full Text] [Related]
8. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557
[TBL] [Abstract][Full Text] [Related]
9. High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.
Jensen AD; Poulakis M; Nikoghosyan AV; Welzel T; Uhl M; Federspil PA; Freier K; Krauss J; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
Radiother Oncol; 2016 Feb; 118(2):272-80. PubMed ID: 26164774
[TBL] [Abstract][Full Text] [Related]
10. Combined Photon and Carbon Ion Radiation Therapy for Sinonasal Malignancies: Results of the HIT-SNT Prospective Phase 2 Trial.
Weusthof K; Held T; Lang K; Rachel ZE; Harrabi SB; Plath K; Freudlsperger C; Herfarth K; Debus J; Haberer T; Münter M; Jensen AD; Adeberg S
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1563-1574. PubMed ID: 37866761
[TBL] [Abstract][Full Text] [Related]
11. A retrospective multicenter study of carbon-ion radiotherapy for major salivary gland carcinomas: Subanalysis of J-CROS 1402 HN.
Hayashi K; Koto M; Demizu Y; Saitoh JI; Suefuji H; Okimoto T; Ohno T; Shioyama Y; Takagi R; Ikawa H; Nemoto K; Nakano T; Kamada T;
Cancer Sci; 2018 May; 109(5):1576-1582. PubMed ID: 29493851
[TBL] [Abstract][Full Text] [Related]
12. The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck.
Adeberg S; Akbaba S; Lang K; Held T; Verma V; Nikoghosyan A; Bernhardt D; Münter M; Freier K; Plinkert P; Hauswald H; Herfarth K; Rieken S; Debus J; Jensen AD
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):167-173. PubMed ID: 31586664
[TBL] [Abstract][Full Text] [Related]
13. Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12).
Jensen AD; Nikoghosyan AV; Windemuth-Kieselbach C; Debus J; Münter MW
BMC Cancer; 2011 May; 11():190. PubMed ID: 21600049
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas.
Schulz-Ertner D; Nikoghosyan A; Jäkel O; Haberer T; Kraft G; Scholz M; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):391-8. PubMed ID: 12738314
[TBL] [Abstract][Full Text] [Related]
15. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
[TBL] [Abstract][Full Text] [Related]
16. Acute toxicity of combined photon IMRT and carbon ion boost for intermediate-risk prostate cancer - acute toxicity of 12C for PC.
Nikoghosyan AV; Schulz-Ertner D; Herfarth K; Didinger B; Münter MW; Jensen AD; Jäkel O; Hoess A; Haberer T; Debus J
Acta Oncol; 2011 Aug; 50(6):784-90. PubMed ID: 21767175
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux® and particle therapy].
Jensen AD; Nikoghosyan A; Hinke A; Debus J; Münter MW
BMC Cancer; 2011 Feb; 11():70. PubMed ID: 21320355
[TBL] [Abstract][Full Text] [Related]
18. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment.
Münter MW; Schulz-Ertner D; Hof H; Nikoghosyan A; Jensen A; Nill S; Huber P; Debus J
Radiat Oncol; 2006 Jun; 1():17. PubMed ID: 16756669
[TBL] [Abstract][Full Text] [Related]
19. Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.
Jensen AD; Poulakis M; Nikoghosyan AV; Chaudhri N; Uhl M; Münter MW; Herfarth KK; Debus J
Radiother Oncol; 2015 Feb; 114(2):182-8. PubMed ID: 25640299
[TBL] [Abstract][Full Text] [Related]
20. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
